OSLO, Norway, Feb. 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024: NOK 128.6 million), and a commercial EBITDA of NOK 8.4 million (Q4 2024: NOK 3.9 million) for the company. In 2026,...
Hence then, the article about photocure asa results for the fourth quarter of 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Photocure ASA: Results for the fourth quarter of 2025 )
Also on site :
- Trump says Pam Bondi, a loyalist who oversaw Justice Department upheaval, is out as attorney general
- Ford and Toyota issue major South African car recall
- Subway Fans Are Buzzing About This BOGO Footlong Deal—Here’s How to Get It